Utility of antitreponemal IgM testing in the diagnosis of early and repeat syphilis among HIV-infected and non-infected patients

Abstract

Until now only non-treponemal tests (e.g. rapid plasma reagin [RPR]) have been used to monitor syphilis activity (e.g. distinguishing between treated, untreated and repeat disease) and efficacy of treatment. However, they usually require manual operation and are less specific than treponemal tests. The aim of the current study was to evaluate the use of the antitreponemal IgM testing in the diagnosis of early and repeat syphilis in HIV-infected and non-infected patients. One hundred and seventeen patients with early syphilis were included in this prospective study. RPR and anti-Treponema pallidum-IgM (TP-IgM) tests were conducted at onset and at three-month intervals during 24-month follow-up after initial treatment. In 31 of 117 syphilitic patients the co-occurrence of HIV infection was diagnosed. A positive TP-IgM test was present in 78.6% of patients with newly-diagnosed primary syphilis, 95.8% with secondary and 57.9% with early latent syphilis, but only in 38.5% patients with syphilis reinfection. There was a significant correlation between primary and secondary syphilis, higher baseline RPR titre and the pre-treatment IgM test reactivity. Regardless of the syphilis stage, HIV-seropositive individuals were more frequently positive for TP-IgM, both during the first onset of the disease (90.3%), and reinfection (71.4%), as compared to the HIV-seronegative group (71.4% and 0%, respectively, P < 0.03). TP-IgM seroreversion was observed in 115 out of 117 patients studied (98.3%) during follow-up (mean time to seroreversion 6.9 months). The time to TP-IgM seroreversion after treatment was significantly shorter in patients with early symptomatic syphilis (mean 4.9 months) when compared to early latent syphilis (7.7 months, P < 0.05). A negative TP-IgM test was found in approximately 20% and 40% of individuals with primary and early latent syphilis, respectively. The value of IgM testing in the diagnosis of syphilis reinfection is doubtful.

Keywords

HIV diagnosis syphilis,IgM testing

Get full access to this article

View all access options for this article.

References

European Centre for Disease Prevention and Control. Annual Epidemiological Report 2016 – Syphilis. Stockholm: ECDC. www.ecdc.europa.eu/en/publications-data/syphilis-annual-epidemiological-report-2016-2014-data (2016, accessed 14 September 2017).

Sena

White

Sparling

PF.

Novel Treponema pallidum serologic tests: a paradigm shift in syphilis screening for the 21st century. Clin Infect Dis 2010; 51: 700–708.

Baker-Zander

Roddy

Handsfield

et al . IgG and IgM antibody reactivity to antigens of Treponema pallidum after treatment of syphilis. Sex Transm Dis 1986; 13: 214–220.

McMillan

Young

Reactivity in the venereal diseases research laboratory test and the Mercia IgM enzyme immunoassay after treatment of early syphilis. Int J STD AIDS 2008; 19: 689–693.

Lin

Tong

et al . Evaluation of a colloidal gold immunochromatography assay in the detection of Treponema palladium specific IgM antibody in syphilis serofast reaction patients: a serologic marker for the relapse and infection of syphilis. Diagn Microbiol Infect Dis 2011; 70: 10–16.

Case definitions for nationally notifiable infectious diseases. 2015 Sexually Transmitted Diseases Surveillance. Centres for Disease Control and Prevention, www.cdc.gov/std/stats15/appendixc.htm (2016, accessed 5 January 2018).

Strandberg-Pedersen

Sand-Petersen

Axelsen

NH.

Enzyme-linked immunosorbent assay for detection of immunoglobulin M antibody against the Reiter treponeme flagellum in syphilis. J Clin Microbiol 1982; 16: 608–614.

O’Neill P and Nicol

CS.

IgM class antitreponemal antibody in treated and untreated syphilis. Br J Vener Dis 1972; 48: 460–463.

Bosshard

PP.

Usefulness of IgM-specific enzyme immunoassays for serodiagnosis of syphilis: comparative evaluation of three different assays. J Infect 2013; 67: 35–42.

10.

McMillan

Young

Qualitative and quantitative aspects of the serological diagnosis of early syphilis. Int J STD AIDS 2008; 19: 620–624.

11.

Sato

Kubo

Yokota

et al . Treponema pallidum specific IgM haemagglutination test for serodiagnosis of syphilis. Br J Vener Dis 1984; 60: 364–370.

12.

Lin

Zheng

Tong

et al . Further evaluation of the characteristics of Treponema palladium-specific IgM antibody in syphilis serofast reaction patients. Diagn Microbiol Infect Dis 2011; 71: 201–207.

13.

Marangoni

Nardini

Foschi

et al . Evaluation of the BioPlex 2200 Syphilis System as a first-line method of reverse-sequence screening for syphilis diagnosis. Clin Vaccine Immunol 2013; 20: 1084–1088.